Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents

Ho Shin Kim, Van Hai Hoang, Mannkyu Hong, Kyung Chul Kim, Jihyae Ann, Cong Truong Nguyen, Ji Hae Seo, Hoon Choi, Jun Yong Kim, Kyu Won Kim, Woong Sub Byun, Sangkook Lee, Seungbeom Lee, Young Ger Suh, Jie Chen, Hyun Ju Park, Tae Min Cho, Ji Young Kim, Jae Hong Seo, Jeewoo Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

On the basis of deguelin, a series of the B,C-ring truncated surrogates with N-substituted amide linkers were investigated as HSP90 inhibitors. The structure activity relationship of the template was studied by incorporating various substitutions on the nitrogen of the amide linker and examining their HIF-1α inhibition. Among them, compound 57 showed potent HIF-1α inhibition and cytotoxicity in triple-negative breast cancer lines in a dose-dependent manner. Compound 57 downregulated expression and phosphorylation of major client proteins of HSP90 including AKT, ERK and STAT3, indicating that its antitumor activity was derived from the inhibition of HSP90 function. The molecular modeling of 57 demonstrated that 57 bound well to the C-terminal ATP-binding pocket in the open conformation of the hHSP90 homodimer with hydrogen bonding and pi-cation interactions. Overall, compound 57 is a potential antitumor agent for triple-negative breast cancer as a HSP90 C-terminal inhibitor.

Original languageEnglish
Pages (from-to)1370-1381
Number of pages12
JournalBioorganic and Medicinal Chemistry
Volume27
Issue number7
DOIs
Publication statusPublished - 2019 Apr 1

Fingerprint

HSP90 Heat-Shock Proteins
Triple Negative Breast Neoplasms
Breast Neoplasms
Derivatives
Amides
Phosphorylation
Molecular modeling
Hydrogen Bonding
Structure-Activity Relationship
Cytotoxicity
Protein C
Antineoplastic Agents
Conformations
Cations
Hydrogen bonds
Substitution reactions
Nitrogen
Down-Regulation
Adenosine Triphosphate
Proteins

Keywords

  • Antitumor
  • Breast cancer
  • Deguelin
  • Heat shock protein 90
  • HIF-1 α
  • HSP90
  • Hypoxia Inducible Factor-1α

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents. / Kim, Ho Shin; Hoang, Van Hai; Hong, Mannkyu; Chul Kim, Kyung; Ann, Jihyae; Nguyen, Cong Truong; Seo, Ji Hae; Choi, Hoon; Yong Kim, Jun; Kim, Kyu Won; Sub Byun, Woong; Lee, Sangkook; Lee, Seungbeom; Suh, Young Ger; Chen, Jie; Park, Hyun Ju; Cho, Tae Min; Kim, Ji Young; Seo, Jae Hong; Lee, Jeewoo.

In: Bioorganic and Medicinal Chemistry, Vol. 27, No. 7, 01.04.2019, p. 1370-1381.

Research output: Contribution to journalArticle

Kim, HS, Hoang, VH, Hong, M, Chul Kim, K, Ann, J, Nguyen, CT, Seo, JH, Choi, H, Yong Kim, J, Kim, KW, Sub Byun, W, Lee, S, Lee, S, Suh, YG, Chen, J, Park, HJ, Cho, TM, Kim, JY, Seo, JH & Lee, J 2019, 'Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents', Bioorganic and Medicinal Chemistry, vol. 27, no. 7, pp. 1370-1381. https://doi.org/10.1016/j.bmc.2019.02.040
Kim, Ho Shin ; Hoang, Van Hai ; Hong, Mannkyu ; Chul Kim, Kyung ; Ann, Jihyae ; Nguyen, Cong Truong ; Seo, Ji Hae ; Choi, Hoon ; Yong Kim, Jun ; Kim, Kyu Won ; Sub Byun, Woong ; Lee, Sangkook ; Lee, Seungbeom ; Suh, Young Ger ; Chen, Jie ; Park, Hyun Ju ; Cho, Tae Min ; Kim, Ji Young ; Seo, Jae Hong ; Lee, Jeewoo. / Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents. In: Bioorganic and Medicinal Chemistry. 2019 ; Vol. 27, No. 7. pp. 1370-1381.
@article{f46d0ea0c2c4461bbcacc904f3db69ba,
title = "Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents",
abstract = "On the basis of deguelin, a series of the B,C-ring truncated surrogates with N-substituted amide linkers were investigated as HSP90 inhibitors. The structure activity relationship of the template was studied by incorporating various substitutions on the nitrogen of the amide linker and examining their HIF-1α inhibition. Among them, compound 57 showed potent HIF-1α inhibition and cytotoxicity in triple-negative breast cancer lines in a dose-dependent manner. Compound 57 downregulated expression and phosphorylation of major client proteins of HSP90 including AKT, ERK and STAT3, indicating that its antitumor activity was derived from the inhibition of HSP90 function. The molecular modeling of 57 demonstrated that 57 bound well to the C-terminal ATP-binding pocket in the open conformation of the hHSP90 homodimer with hydrogen bonding and pi-cation interactions. Overall, compound 57 is a potential antitumor agent for triple-negative breast cancer as a HSP90 C-terminal inhibitor.",
keywords = "Antitumor, Breast cancer, Deguelin, Heat shock protein 90, HIF-1 α, HSP90, Hypoxia Inducible Factor-1α",
author = "Kim, {Ho Shin} and Hoang, {Van Hai} and Mannkyu Hong and {Chul Kim}, Kyung and Jihyae Ann and Nguyen, {Cong Truong} and Seo, {Ji Hae} and Hoon Choi and {Yong Kim}, Jun and Kim, {Kyu Won} and {Sub Byun}, Woong and Sangkook Lee and Seungbeom Lee and Suh, {Young Ger} and Jie Chen and Park, {Hyun Ju} and Cho, {Tae Min} and Kim, {Ji Young} and Seo, {Jae Hong} and Jeewoo Lee",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.bmc.2019.02.040",
language = "English",
volume = "27",
pages = "1370--1381",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents

AU - Kim, Ho Shin

AU - Hoang, Van Hai

AU - Hong, Mannkyu

AU - Chul Kim, Kyung

AU - Ann, Jihyae

AU - Nguyen, Cong Truong

AU - Seo, Ji Hae

AU - Choi, Hoon

AU - Yong Kim, Jun

AU - Kim, Kyu Won

AU - Sub Byun, Woong

AU - Lee, Sangkook

AU - Lee, Seungbeom

AU - Suh, Young Ger

AU - Chen, Jie

AU - Park, Hyun Ju

AU - Cho, Tae Min

AU - Kim, Ji Young

AU - Seo, Jae Hong

AU - Lee, Jeewoo

PY - 2019/4/1

Y1 - 2019/4/1

N2 - On the basis of deguelin, a series of the B,C-ring truncated surrogates with N-substituted amide linkers were investigated as HSP90 inhibitors. The structure activity relationship of the template was studied by incorporating various substitutions on the nitrogen of the amide linker and examining their HIF-1α inhibition. Among them, compound 57 showed potent HIF-1α inhibition and cytotoxicity in triple-negative breast cancer lines in a dose-dependent manner. Compound 57 downregulated expression and phosphorylation of major client proteins of HSP90 including AKT, ERK and STAT3, indicating that its antitumor activity was derived from the inhibition of HSP90 function. The molecular modeling of 57 demonstrated that 57 bound well to the C-terminal ATP-binding pocket in the open conformation of the hHSP90 homodimer with hydrogen bonding and pi-cation interactions. Overall, compound 57 is a potential antitumor agent for triple-negative breast cancer as a HSP90 C-terminal inhibitor.

AB - On the basis of deguelin, a series of the B,C-ring truncated surrogates with N-substituted amide linkers were investigated as HSP90 inhibitors. The structure activity relationship of the template was studied by incorporating various substitutions on the nitrogen of the amide linker and examining their HIF-1α inhibition. Among them, compound 57 showed potent HIF-1α inhibition and cytotoxicity in triple-negative breast cancer lines in a dose-dependent manner. Compound 57 downregulated expression and phosphorylation of major client proteins of HSP90 including AKT, ERK and STAT3, indicating that its antitumor activity was derived from the inhibition of HSP90 function. The molecular modeling of 57 demonstrated that 57 bound well to the C-terminal ATP-binding pocket in the open conformation of the hHSP90 homodimer with hydrogen bonding and pi-cation interactions. Overall, compound 57 is a potential antitumor agent for triple-negative breast cancer as a HSP90 C-terminal inhibitor.

KW - Antitumor

KW - Breast cancer

KW - Deguelin

KW - Heat shock protein 90

KW - HIF-1 α

KW - HSP90

KW - Hypoxia Inducible Factor-1α

UR - http://www.scopus.com/inward/record.url?scp=85062157105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062157105&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2019.02.040

DO - 10.1016/j.bmc.2019.02.040

M3 - Article

C2 - 30827868

AN - SCOPUS:85062157105

VL - 27

SP - 1370

EP - 1381

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 7

ER -